DCTH — DELCATH SYSTEMS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 872912 ·
Last close
$19.37
Market Cap
$673.84M
52W High
$22.51
52W Low
$8.12
ADV30
621,023
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 35,102,000 | 31,184,000 | 7,116,000 | 6,952,000 | 149,090,000 | 55,538,000 | 15,553,000 |
| Jun 2026 | 29,133,000 | 26,148,000 | 2,395,000 | 2,668,000 | 137,018,000 | 47,521,000 | 15,873,000 |
| Mar 2026 | 24,994,000 | 21,258,000 | -1,637,000 | -1,070,000 | 124,838,000 | 41,313,000 | 12,128,000 |
| Dec 2025 | 20,728,000 | 17,718,000 | -2,184,000 | -1,896,000 | 123,632,000 | 43,454,000 | 12,413,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,993,000
Investing CF
$-2,896,000
Financing CF
$-6,267,000
CapEx
$-2,883,000
Dividends Paid
—
Buybacks
$-3,011,000
EPS Diluted TTM
$0.16
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-520,298,000
Inventory
$10,501,000
Receivables
$20,815,000
ST Investments
$48,777,000
EBIT TTM
$5,690,000
Pretax Income TTM
$8,884,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$109,957,000
EBITDA
$6,138,000
Free Cash Flow
$19,479,250
Enterprise Value
$612,987,776
Total Cash
$104,315,000
Total Debt
$2,408,000
Shares Out
34,788,068
Trailing EPS
$0.16
Book Value
$3.84
ROE
5.4%
ROA
2.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 85,231,000 | 660,000 | 2,700,000 | 123,632,000 | 12,413,000 | 111,219,000 | 22,516,000 |
| Dec 2024 | 37,205,000 | -12,410,000 | -26,386,000 | 76,589,000 | 7,843,000 | 68,746,000 | -18,681,000 |
| Dec 2023 | 2,065,000 | -38,182,000 | -47,678,000 | 38,613,000 | 22,836,000 | 15,777,000 | -31,251,000 |
| Dec 2022 | 2,719,000 | -33,853,000 | -36,508,000 | 17,862,000 | 23,721,000 | -5,859,000 | -24,950,000 |
TTM Snapshot
Revenues TTM
$95,418,000
NetIncome TTM
$532,000
OpCashFlow TTM
—
Assets (Latest)
$137,018,000
Forward EPS
$0.27
Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $19.70 · call volume: 25 · put volume: 201Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BVS | Bioventus Inc. | $725.83M | $10.60 | — |
| INMD | InMode Ltd. | $743.47M | $12.92 | — |
| STVN | Stevanato Group S.p.A. | $759.94M | $15.25 | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $583.56M | $26.05 | — |
| SGHT | Sight Sciences, Inc. | $583.02M | $10.49 | — |
News headlines (Yahoo Finance, 1h cache)
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-17 21:01 · Yahoo
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable
2026-11-13 12:55 · Yahoo
Delcath Systems, Inc. (DCTH) is a Great Momentum Stock: Should You Buy?
2026-11-12 16:00 · Yahoo
Wall Street Analysts Think Delcath Systems (DCTH) Could Surge 27.7%: Read This Before Placing a Bet
2026-11-12 13:55 · Yahoo
Delcath Systems to Be Featured on "Health Uncensored with Dr. Drew" in Segment Highlighting Advances in Liver-Directed Cancer Treatment
2026-11-11 21:01 · Yahoo
Delcath (DCTH) Q3 2026 Earnings Call Transcript
2026-11-09 18:13 · Yahoo
Delcath Systems, Inc. Q3 2026 Earnings Call Summary
2026-11-09 17:48 · Yahoo
Delcath Systems Reports 70% Revenue Growth in Q3 2026 and Raises Full-Year Guidance to $115 Million–$117 Million
2026-11-09 15:44 · Yahoo
Delcath Systems Q3 Earnings Call Highlights
2026-11-09 15:14 · Yahoo
Delcath Systems, Inc. (DCTH) Q3 Earnings and Revenues Top Estimates
2026-11-09 13:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.